Supernus Pharmaceuticals (SUPN) Asset Utilization Ratio (2012 - 2026)
Supernus Pharmaceuticals (SUPN) posted quarterly Asset Utilization Ratio of 0.54 for Q2 2026, up 10.44% year-over-year from 0.49 in Q2 2025, and up 7.52% on a QoQ basis from 0.5 in Q4 2025.
Supernus Pharmaceuticals (SUPN) Asset Utilization Ratio (2012 - 2026) Analysis & Trends
Supernus Pharmaceuticals has reported Asset Utilization Ratio for 15 years, with the latest figure at 0.54 in Q2 2026.
- Asset Utilization Ratio for Q2 2026 came in at 0.54, up 10.44% year-over-year; the trailing twelve-month figure through Jun 2026 was 0.54 (up 10.44% YoY), and the FY2025 annual result was 0.51, up 1.89% from the prior year.
- Asset Utilization Ratio climbed to 0.54 in Q2 2026, from 0.5 in the prior quarter.
- Over five years, Asset Utilization Ratio peaked at 0.54 in Q2 2026 and troughed at 0.36 in Q1 2022.
- A 5-year average of 0.45 and a median of 0.47 in 2023 frame the typical range for Asset Utilization Ratio.
- The widest annual swing landed in 2023, when Asset Utilization Ratio increased 21.75%; it then retreated 0.82% in 2025.
- A 5-year view of Asset Utilization Ratio shows it stood at 0.39 in 2022, then climbed by 20.64% to 0.47 in 2023, then advanced by 2.99% to 0.49 in 2024, then advanced by 2.52% to 0.5 in 2025, then gained by 7.52% to 0.54 in 2026.
- Per Business Quant data, the three most recent Asset Utilization Ratio figures were 0.54 in Q2 2026, 0.5 in Q4 2025, and 0.49 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 0.43 |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 0.63 |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 0.47 |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 0.45 |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 0.41 |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 0.66 |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 0.37 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Supernus Pharmaceuticals | 2.75 Bn | 2.38 Bn | 185.39 Mn | 0.54 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.54 |
| Dec 31, 2025 | 0.50 |
| Sep 30, 2025 | 0.49 |
| Jun 30, 2025 | 0.49 |
| Mar 31, 2025 | 0.49 |
| Dec 31, 2024 | 0.49 |
| Sep 30, 2024 | 0.49 |
| Jun 30, 2024 | 0.48 |
| Mar 31, 2024 | 0.46 |
| Dec 31, 2023 | 0.47 |
| Sep 30, 2023 | 0.47 |
| Jun 30, 2023 | 0.41 |
| Mar 31, 2023 | 0.38 |
| Dec 31, 2022 | 0.39 |
| Sep 30, 2022 | 0.39 |
| Jun 30, 2022 | 0.38 |
| Mar 31, 2022 | 0.36 |
| Dec 31, 2021 | 0.36 |
| Sep 30, 2021 | 0.36 |
| Jun 30, 2021 | 0.37 |